SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-19-000298
Filing Date
2019-04-19
Accepted
2019-04-19 14:19:04
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss133623_sc13g.htm SC 13G 87961
2 JOINT FILING AGREEMENT ss133623_ex99a.htm EX-99.A 15371
  Complete submission text file 0000947871-19-000298.txt   104984
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90199 | Film No.: 19757695
SIC: 2836 Biological Products, (No Diagnostic Substances)